Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | beta-site APP-cleaving enzyme 1 | Starlite/ChEMBL | References |
Homo sapiens | cathepsin D | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin X | cathepsin D | 412 aa | 339 aa | 28.9 % |
Plasmodium falciparum | plasmepsin VII | beta-site APP-cleaving enzyme 1 | 401 aa | 352 aa | 21.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | neuropeptide receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | alpha-1 adrenergic receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | opsin-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | neuropeptide receptor | 0.021 | 0.0028 | 0.0028 |
Giardia lamblia | Hypothetical protein | 0.329 | 0.5699 | 0.5 |
Schistosoma mansoni | muscarinic acetylcholine (GAR) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | neuropeptide receptor | 0.5625 | 1 | 1 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | thyrotropin-releasing hormone receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | growth hormone secretagogue receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | hypothetical protein | 0.021 | 0.0028 | 0.0028 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.548 | 0.9733 | 0.9823 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.5574 | 0.9906 | 1 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.0028 | 0.0028 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.548 | 0.9733 | 0.9823 |
Schistosoma mansoni | biogenic amine receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0251 | 0.0103 | 0.0076 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | hypothetical protein | 0.021 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.3196 | 0.5526 | 0.5566 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2378 | 0.4021 | 0.3997 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0251 | 0.0103 | 0.0076 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5574 | 0.9906 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5574 | 0.9906 | 1 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | myosin xvIII | 0.021 | 0.0028 | 0.0028 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.2378 | 0.4021 | 0.3997 |
Schistosoma mansoni | neuropeptide receptor | 0.021 | 0.0028 | 0.0028 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5574 | 0.9906 | 1 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0535 | 0.0626 | 0.0626 |
Schistosoma mansoni | neuropeptide F-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine receptor | 0.021 | 0.0028 | 0.0028 |
Giardia lamblia | Hypothetical protein | 0.329 | 0.5699 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0251 | 0.0103 | 0.0076 |
Schistosoma mansoni | peptide (allatostatin/somatostatin)-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.0028 | 0.0028 |
Mycobacterium ulcerans | hypothetical protein | 0.329 | 0.5699 | 1 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | adenoreceptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | opsin-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | hypothetical protein | 0.021 | 0.0028 | 0.0028 |
Brugia malayi | Cytochrome P450 family protein | 0.0251 | 0.0103 | 1 |
Onchocerca volvulus | 0.5574 | 0.9906 | 1 | |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.548 | 0.9733 | 0.9823 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.5574 | 0.9906 | 0.9906 |
Schistosoma mansoni | peptide (allatostatin)-like receptor | 0.021 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.548 | 0.9733 | 0.9825 |
Brugia malayi | Cytochrome P450 family protein | 0.0251 | 0.0103 | 1 |
Schistosoma mansoni | neuropeptide F-like receptor | 0.021 | 0.0028 | 0.0028 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.329 | 0.5699 | 1 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.0028 | 0.0028 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.5574 | 0.9906 | 0.9906 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | histamine h1 receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | neuropeptide f receptor 76f | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | ancient conserved domain protein 2 (cyclin m2) | 0.021 | 0.0028 | 0.0028 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.5625 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.021 | 0.0028 | 0.0028 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.329 | 0.5699 | 0.5 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.021 | 0.0028 | 0.0028 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2378 | 0.4021 | 0.3997 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.548 | 0.9733 | 0.9823 |
Schistosoma mansoni | biogenic amine receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | opsin-like receptor | 0.021 | 0.0028 | 0.0028 |
Echinococcus multilocularis | neuropeptide receptor | 0.5625 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2378 | 0.4021 | 0.3997 |
Schistosoma mansoni | histamine-responsive GPCR (AAF21638) | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | peptide (FMRFamide/neurokinin-3)-like receptor | 0.021 | 0.0028 | 0.0028 |
Schistosoma mansoni | 6-phosphofructokinase | 0.5574 | 0.9906 | 0.9906 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5574 | 0.9906 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1 nM | Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay | ChEMBL. | 23856050 |
IC50 (binding) | = 6 nM | Inhibition of recombinant BACE-1 (unknown origin) expressed in Escherichia coli using biotinylated peptide substrate treated 20 mins before substrate addition measured after 3 hrs by fluorescence polarization assay | ChEMBL. | 23856050 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.